Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Pachter

Patterns of Duvelisib-Induced Lymphocytosis in Patients With R/R CLL or SLL Including Those With High-Risk Factors Treated in the Duo Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Related publications

Effect of Dose Modifications on Response to Duvelisib in Patients With Relapsed/Refractory CLL/SLL in the Duo Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Extended Follow-Up and Impact of High-Risk Prognostic Factors From the Phase 3 RESONATE Study in Patients With Previously Treated CLL/SLL

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

Safety and Efficacy of Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

FIRST-LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL-A COMPARISON OF STUDY PATIENTS TREATED WITH R-Chop ON THE RICOVER-60 TRIAL AND PATIENTS TREATED WITH R-Cyclophosphamide, EPIRUBICIN, VINDESINE, PREDNISONE (R-EpiVDSP) AT PEKING UNIVERSITY

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The PI3Kδ INHIBITOR ME-401 ± RITUXIMAB IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL), CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-Chop or R-Chop-Like Chemotherapy

Journal of Clinical Medicine Research
2014English

Blood Lymphocyte-To-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated With R-Chop

PLoS ONE
Multidisciplinary
2012English

Possible Risk Factors Associated With Relapse in Patients Treated With Neoadjuvant Chemohormonal Therapy for High Risk Prostate Cancer

The Open Prostate Cancer Journal
2011English

Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy